The U.S. Supreme Court on Thursday blocked OxyContin maker Purdue Pharma’s bankruptcy settlement that would have shielded its wealthy Sackler family owners from lawsuits over their role in the nation’s deadly opioid epidemic. The 5-4 decision reversed a lower court’s …
OxyContin maker Purdue Pharma can start executing a settlement that protects members of the Sackler family who own the company from civil lawsuits over the toll of opioids, a court ruled Tuesday. The ruling from the 2nd U.S. Circuit Court …
More than a year after OxyContin maker Purdue Pharma reached a tentative settlement over the toll of opioids that was accepted nearly universally by the groups suing the company – including thousands of people injured by the drug – money …
The head of McKinsey & Co. acknowledged that it failed to see the opioid epidemic unfolding while simultaneously doing work for drug regulators and makers of painkillers including OxyContin in his first appearance before lawmakers investigating the consulting firm’s actions. …
A $6 billion deal hangs in the balance as OxyContin maker Purdue Pharma LP and its wealthy owners square off against the U.S. Justice Department over the firm’s opioid lawsuit settlement. The sides will meet in a New York courtroom …
Members of the billionaire Sackler family that own Purdue Pharma LP are weighing whether to add $1 billion to the OxyContin-maker’s faltering opioid settlement bid in an effort to win over holdouts, according to people familiar with the offer. The …
Members of the Sackler family who own Purdue Pharma LP are nearing an agreement to boost their more than $4 billion offer to resolve sprawling opioid litigation after negotiating with states that had objected to terms of the OxyContin maker’s …
A unit of French advertising company Publicis Groupe SA on Friday lost a bid to dismiss a lawsuit by Massachusetts’ attorney general claiming it helped OxyContin maker Purdue Pharma LP fuel the U.S. opioid epidemic. Publicis Health had called Attorney …
A U.S. judge on Monday approved up to $7.1 million in bonuses for five executives of Purdue Pharma, the bankrupt maker of OxyContin, at a hearing at which he faced blunt criticism for his handling of the case from a …
A federal bankruptcy judge on Friday urged states that oppose a settlement plan with Purdue Pharma to try to work out differences with the OxyContin maker before he issues a ruling next week. During a videoconference hearing, Judge Robert Drain …
